Lab
Dynix Diagnostix
Dynix Diagnostix was paid $103K by Medicaid between Aug 2018 and May 2023, across 35 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 76% of everything it billed.
33Billing provider infoDYNIX DIAGNOSTIX
FORT PIERCE, FL 34946
FORT PIERCE, FL 34946
33aNPI1760930697assigned 09/20/2016
33bProvider typeClinical Medical Laboratory
28Total paid$103K
24GClaims9,413
24DCodes billed35
24AFirst – last monthAug 2018 – May 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#103 of 225
Median peer was paid$74K
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 900 | $0.00 | |
| 2019 | 3,352 | $14.87 | |
| 2020 | 79 | $3K | |
| 2021 | 1,615 | $36K | |
| 2022 | 2,413 | $61K | |
| 2023 | 1,054 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 76% | 1,395 | 1,226 | $78K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 11% | 1,187 | 1,037 | $11K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 10% | 894 | 790 | $10K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 2.2% | 1,140 | 1,078 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 218 | 168 | $315.15 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 290 | 80 | $158.64 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 216 | 186 | $93.84 |
| 82746 | <1% | 29 | 25 | $14.87 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 0% | 430 | 324 | $0.00 |
| 85027 | 0% | 117 | 105 | $0.00 | |
| 84478 | 0% | 41 | 40 | $0.00 | |
| 84075 | 0% | 126 | 119 | $0.00 |
23 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 182 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 324 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 316 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 217 | $0.00 |
| 82607 | 0% | 72 | $0.00 | |
| 82435 | 0% | 144 | $0.00 | |
| 84132 | 0% | 155 | $0.00 | |
| 82040 | 0% | 130 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 51 | $0.00 |
| 80050 | General health panel | 0% | 12 | $0.00 |
| 84460 | 0% | 121 | $0.00 | |
| 82374 | 0% | 155 | $0.00 | |
| 82247 | 0% | 121 | $0.00 | |
| 80061 | Lipid panel | 0% | 171 | $0.00 |
| 82310 | 0% | 196 | $0.00 | |
| 82947 | 0% | 182 | $0.00 | |
| 83718 | 0% | 42 | $0.00 | |
| 84450 | 0% | 121 | $0.00 | |
| 82565 | 0% | 156 | $0.00 | |
| 84155 | 0% | 120 | $0.00 | |
| 84295 | 0% | 156 | $0.00 | |
| 82465 | 0% | 42 | $0.00 | |
| 84520 | 0% | 144 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALTERMAN, SEAN (CHIEF OPERATING OFFICER)